|
|
 |
|
Viewing report
|
|
|
|
Pre-clinical Stage Partnering Agreements?in Biopharma
CurrentPartnering, Oct 2008, Pages: 280
The Pre-clinical Stage Partnering Agreements in Biopharma report details an understanding and analysis of how and why companies enter pre-clinical stage licensing/business development and other forms of partnering arrangement.
The report provides a detailed understanding and analysis of how and why companies enter pre-clinical stage licensing/business development and other forms of partnering arrangement.
The focus of the report is on partnerships for pre-clinical stage compounds where partners have joined forces to exploit these early stage opportunities. This is an early stage of partnering undertaken by commercial entities with the objective of utilizing lead molecules and pre-clinical compounds to progress into clinical stage pipeline development.
The report provides access to average pre-clinical stage deal payment terms as announced between the parties. This data provides useful insight into the average and range of payments for upfront, milestone and royalty payments agreed for pre-clinical stage deals.
This report contains over 800 links to online copies of actual pre-clinical stage contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners.
Key benefits
Pre-clinical Stage Partnering Agreements in Biopharma provides the reader with the following key benefits:
- In-depth understanding of pre-clinical stage partnering deal trends since 2000
- Analysis of the structure of pre-clinical stage partnering agreements with numerous real life case studies
- Comprehensive access to over 800 actual pre-clinical stage partnering contracts entered into by the world’s biopharma companies*
- Detailed access to actual pre-clinical stage partnering contracts enter into by the leading fifty bigpharma companies*
- Insight into the payment and deal terms included in a pre-clinical stage partnering agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
*Subject to being published via regulatory requirements of the Securities Exchange Commission.
Report scope
Pre-clinical Stage Partnering Agreements in Biopharma is intended to provide the reader with an in-depth understanding of the pre-clinical stage partnering trends and structure of deals entered into by leading biopharma companies worldwide.
Pre-clinical Stage Partnering Agreements in Biopharma includes:
- Trends in pre-clinical stage partnering dealmaking in the biopharma industry since 2000
- Analysis of pre-clinical stage partnering deal structure
- Average payment terms for pre-clinical stage deals
- Case studies of real-life pre-clinical stage partnering deals
- Access to over 1000 pre-clinical stage partnering contract documents
- The leading pre-clinical stage partnering deals by value since 2000
- Most active pre-clinical stage partnering dealmakers since 2000
- The leading pre-clinical stage partnering resources
Customers who bought this item also bought
Pre-clinical Stage Partnering Agreements?in Biopharma
Discovery Stage Partnering Agreements?in Biopharma
Bigpharma Partnering Agreements
Distribution Agreements?in Biopharma
Manufacturing and Supply Agreements?in Biopharma
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Partnering?with Bigpharma: The Definitive Guide to Partnering Interests, Contacts & Agreements
King Partnering Guide 2008
|
|
|
|
